HOME > Investors >
Press Releases
2018-05-23
VM BioPharma Presents at Pain Therapeutics Conference in UK
2018-05-18
Reyon’s Lawsuit Dismissed by Court
2018-05-15
Five Korean Companies’ Stocks Join MSCI Index
2018-05-10
Global Market Report Forecasts ViroMed’s VM202 Will Become First Disease-Modifying Drug for PDPN
2018-04-17
ViroMed’s DPN Clinical Trial Passes 70% Point in Patient Randomization
1
2
3
4
5
6
7
8
9
10
